Related Experiment Video

Updated: Jul 8, 2026

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions
07:30

Evaluation of the Cognitive Performance of Hypertensive Patients with Silent Cerebrovascular Lesions

Published on: April 23, 2021

Diagnosis and management of vascular cognitive impairment

David L Nyenhuis1, Philip B Gorelick

  • 1Department of Neurology and Rehabilitation Medicine, University of Illinois at Chicago, Center for Stroke Research, 1645 West Jackson Boulevard, Suite #400, Chicago, IL 60612, USA. nyenhuis@uic.edu

Current Atherosclerosis Reports
|January 5, 2008
PubMed

Insights

Diagnosing vascular cognitive impairment (VCI) is challenging due to varying criteria and difficulty distinguishing it from Alzheimer's disease (AD). New harmonization criteria and improved treatments are needed for better VCI management and patient outcomes.

Area of Science:

  • Neurology
  • Neuroscience
  • Public Health

Background:

  • Accurate diagnosis of vascular cognitive impairment (VCI) is crucial but complicated by the need to identify cognitive impairment, cerebrovascular disease (CVD), their causal links, and other contributing factors like Alzheimer's disease (AD).
  • Current diagnostic systems for VCI lack standardization, leading to inconsistent prevalence rates and difficulties in differentiating pure VCI from mixed AD and CVD presentations.

Purpose of the Study:

  • To address the diagnostic challenges in vascular cognitive impairment (VCI).
  • To introduce and validate the National Institute of Neurological Disorders and Stroke (NINDS) harmonization criteria for VCI.
  • To highlight the need for improved management and therapeutic strategies for VCI.

Main Methods:

  • Review and analysis of existing diagnostic criteria for VCI.
  • Introduction of the NINDS harmonization criteria for VCI study and validation.
  • Examination of current VCI management strategies, focusing on risk factor control and treatment efficacy.

Main Results:

  • Existing diagnostic systems for VCI show significant variability and limitations in differentiating conditions.
  • The NINDS harmonization criteria offer a standardized approach to VCI diagnosis.
  • Current treatments for VCI provide statistical benefits but lack consistent global clinical efficacy.

Conclusions:

  • Standardized diagnostic criteria, such as the NINDS harmonization criteria, are essential for accurate VCI assessment.
  • Effective VCI management requires aggressive control of atherogenic risk factors.
  • Future research should focus on developing novel therapeutic agents and refining primary prevention strategies for VCI.

More Related Videos

Using Retinal Imaging to Study Dementia09:17

Using Retinal Imaging to Study Dementia

Published on: November 6, 2017

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis05:12

A Mouse Model for Vascular Cognitive Impairment and Dementia Based on Needle-guided Asymmetric Bilateral Common Carotid Artery Stenosis

Published on: November 22, 2024

Related Concept Videos

Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...